Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non-Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: February 16, 2026
Stereotactic Radiosurgery Dose Reduction for Patients With Brain Metastases From Non-Small Cell Lung Primary on Immunotherapy or Targeted Therapy.
Journal: Neurosurgery
Published: September 25, 2025
Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis.
Journal: Frontiers in oncology
Published: July 31, 2025
Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: May 06, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer.
Journal: Clinical lung cancer
Published: March 14, 2025
Successful Treatment of Innumerable Untreated Brain Metastases With Trastuzumab Deruxtecan in Chemotherapy-Naïve HER2-Mutated Non-Small-Cell Lung Cancer.
Journal: Case reports in oncological medicine
Published: January 06, 2025
Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients With Untreated Brain Metastases.
Journal: Clinical lung cancer
Published: January 02, 2025
First Report of Response to Tarlatamab in a Patient With DLL3-Positive Pulmonary Carcinoid: Case Report.
Journal: JTO clinical and research reports
Published: December 02, 2024
Osimertinib for uncommon EGFR mutations: herding UNICORNs in a field of horses.
Journal: Translational cancer research
Published: October 11, 2024
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: August 13, 2024
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024
Last Updated: 09/26/2026